[Evaluation of gatifloxacin-based triple therapy for refractory H. pylori].
Watanabe
Kazuhiro
K
Third Department of Internal Medicine, Kyorin University School of Medicine, Japan.
D000368:Aged; D000658:Amoxicillin / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D017291:Clarithromycin / Q000008:administration & dosage; D004341:Drug Evaluation; D004359:Drug Therapy, Combination / Q000008:administration & dosage*; D005260:Female; D024841:Fluoroquinolones / Q000008:administration & dosage*; D000077734:Gatifloxacin; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D000658:Amoxicillin; D017291:Clarithromycin; D000077734:Gatifloxacin